Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 3, 2026

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants
11:39

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants

Published on: March 14, 2013

[Neonatal brain hypothermia].

Masaki Shimizu1

  • 1Division of Neonatology, Saitama Children's Medical Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 16, 2011
PubMed
Summary

Neonatal therapeutic hypothermia helps hypoxic-ischemic encephalopathy (HIE) but is insufficient for severe cases. New strategies targeting NMDA receptors are needed to protect basal ganglia regions in severe HIE.

Related Concept Videos

Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum cytokine profiling reveals distinct inflammatory signatures in Kawasaki disease and MIS-C and suggests associations with coronary artery lesions.

Pediatric research·2026
Same author

Successful Treatment of Tubulointerstitial Nephritis With Uveitis Syndrome Using Adalimumab.

Pediatrics international : official journal of the Japan Pediatric Society·2026
Same author

Pericaval Fat Collection in a Patient With Systemic Juvenile Idiopathic Arthritis.

International journal of rheumatic diseases·2026
Same author

Cerebral Blood Volume Within 6 Hours of Birth in Hypoxic-Ischemic Encephalopathy Assessed Using Time-Resolved Near-Infrared Spectroscopy.

American journal of perinatology·2026
Same author

Functional characterization of Griscelli syndrome type 2 sine albinism in Japanese patients.

Journal of human immunity·2026
Same author

Case Series: Serum CXCL9 and sTNF-RII Levels as Useful Disease Activity Markers in Patients With COVID-19-Associated Multisystem Inflammatory Syndrome in Children.

International journal of rheumatic diseases·2026

Area of Science:

  • Neuroscience
  • Neonatal Medicine
  • Biomedical Engineering

Context:

  • Neonatal hypoxic-ischemic encephalopathy (HIE) is a serious condition requiring effective treatments.
  • Therapeutic hypothermia is a current standard of care for HIE, reducing secondary brain injury.
  • Severe HIE cases show limited improvement with hypothermia alone, particularly affecting basal ganglia regions.

Purpose:

  • To investigate the limitations of current therapeutic hypothermia for severe neonatal HIE.
  • To explore the role of NMDA receptors in the vulnerability of basal ganglia regions to ischemic injury.
  • To propose the development of novel neuroprotective strategies for severe HIE.

Summary:

  • Therapeutic hypothermia effectively treats neonatal hypoxic-ischemic encephalopathy (HIE) by mitigating secondary energy failure.
  • However, its efficacy is limited in severe HIE cases, where basal ganglia injury leads to permanent handicaps.
  • The NMDA receptor's presence in basal ganglia is hypothesized as a key factor in their fragility, necessitating new therapeutic approaches.

Impact:

  • Highlights the need for advanced neuroprotective therapies beyond hypothermia for severe HIE.
  • Suggests NMDA receptor modulation as a potential therapeutic target for preventing basal ganglia damage.
  • Aims to improve long-term outcomes for infants suffering from severe HIE and associated neurological deficits.

More Related Videos

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
08:47

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia

Published on: November 19, 2008

Related Experiment Videos

Last Updated: Jun 3, 2026

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants
11:39

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants

Published on: March 14, 2013

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
08:47

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia

Published on: November 19, 2008